NCT06940076 is a Phase 2 clinical trial of gayo arabica coffee skin extract cream in Skin Aging, sponsored by Wahyu Lestari.

Who is sponsoring NCT06940076?

NCT06940076 is sponsored by Wahyu Lestari.

What drugs are being tested in NCT06940076?

Interventions in NCT06940076: gayo arabica coffee skin extract cream.

What condition does NCT06940076 study?

NCT06940076 studies Skin Aging.

Is NCT06940076 still recruiting?

NCT06940076 is currently completed. Last updated 23 April 2025.

Last reviewed 2025-04-23 · How we verify

NCT06940076

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Potential of Gayo Arabica Coffee Skin

Completed Phase 2 Last updated 23 April 2025

What this trial tests

Phase 2 trial testing gayo arabica coffee skin extract cream in Skin Aging in 40 participants. Completed in 30 November 2024.

Timeline

1 March 2024

Primary endpoint
30 June 2024

30 November 2024

Quick facts

Lead sponsor	Wahyu Lestari
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 March 2024
Primary completion	30 June 2024
Estimated completion	30 November 2024
Sites	1 location across Indonesia

Drugs / interventions tested

gayo arabica coffee skin extract cream — full drug profile →

Conditions studied

Skin Aging — all drugs for Skin Aging →

Sponsor

Wahyu Lestari — full company profile →

Who can join

Adults 30 to 60, female only, with Skin Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to assess the effectiveness of gayo arabica coffee skin extract cream in the prevention of skin aging

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Skin Aging

Currently open trials in the same condition.

NCT07381218 — Focused Ultrasound Treatment for Facial Skin Laxity · NA · active not recruiting
NCT06900660 — Evaluation of the Skin-Beautifying Effects of Collagen Drinks · NA · active not recruiting
NCT06804772 — A Clinical Study to Evaluate the Efficacy of Activated Silk™ 27P-α in Subjects, Aged 35-65 Years of Age, to Improve the · NA · active not recruiting
NCT06816069 — Study on Safety and Efficacy of Monopolar Radio Frequency Device for Facial Skin Tightening · NA · active not recruiting
NCT06727292 — Biometrical Evaluation of the Efficacy of a Food Supplement Versus Placebo · NA · recruiting

Other Wahyu Lestari trials

Trials by the same sponsor.

NCT05390489 — The Effect of Arabica Gayo Cascara Pulp Extract on Photoaging · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06940076 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wahyu Lestari
Last refreshed: 23 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06940076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing